Björn Glinghammar

1.4k total citations
27 papers, 956 citations indexed

About

Björn Glinghammar is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Björn Glinghammar has authored 27 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Björn Glinghammar's work include Drug-Induced Hepatotoxicity and Protection (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Björn Glinghammar is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Björn Glinghammar collaborates with scholars based in Sweden, United Kingdom and United States. Björn Glinghammar's co-authors include Joseph Rafter, Ewa Ehrenborg, Ian A. Cotgreave, Anders Hamsten, Josefin Skogsberg, Marco Venturi, Jan Andersson, Petra Thulin, Ingalill Rafter and Heike Hellmold and has published in prestigious journals such as Gastroenterology, American Journal of Clinical Nutrition and Biochemical and Biophysical Research Communications.

In The Last Decade

Björn Glinghammar

26 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Björn Glinghammar Sweden 18 417 247 217 189 150 27 956
Norimasa Miura Japan 15 385 0.9× 152 0.6× 116 0.5× 149 0.8× 201 1.3× 40 949
Alaa E. El‐Sisi Egypt 17 312 0.7× 114 0.5× 189 0.9× 132 0.7× 107 0.7× 58 958
Chao Guo China 19 520 1.2× 120 0.5× 167 0.8× 147 0.8× 196 1.3× 53 1.1k
Qichao Hu China 16 412 1.0× 106 0.4× 190 0.9× 212 1.1× 137 0.9× 43 1.0k
Yanqin Bian China 17 456 1.1× 99 0.4× 194 0.9× 232 1.2× 60 0.4× 35 984
Kaili Fu China 12 573 1.4× 181 0.7× 102 0.5× 461 2.4× 138 0.9× 14 1.1k
Sandra Kalthoff Germany 13 303 0.7× 138 0.6× 235 1.1× 169 0.9× 43 0.3× 23 831
Nghia Nguyen United States 19 589 1.4× 382 1.5× 436 2.0× 177 0.9× 144 1.0× 31 1.4k
Jonathan P. Jackson United States 15 233 0.6× 279 1.1× 302 1.4× 333 1.8× 41 0.3× 21 821

Countries citing papers authored by Björn Glinghammar

Since Specialization
Citations

This map shows the geographic impact of Björn Glinghammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Glinghammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Glinghammar more than expected).

Fields of papers citing papers by Björn Glinghammar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Glinghammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Glinghammar. The network helps show where Björn Glinghammar may publish in the future.

Co-authorship network of co-authors of Björn Glinghammar

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Glinghammar. A scholar is included among the top collaborators of Björn Glinghammar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Glinghammar. Björn Glinghammar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glinghammar, Björn, et al.. (2023). hERG-toxicity prediction using traditional machine learning and advanced deep learning techniques. Current Research in Toxicology. 5. 100121–100121. 10 indexed citations
2.
Thulin, Petra, Krister Bamberg, Marcin Buler, Björn Dahl, & Björn Glinghammar. (2016). The peroxisome proliferator-activated receptor α agonist, AZD4619, induces alanine aminotransferase-1 gene and protein expression in human, but not in rat hepatocytes: Correlation with serum ALT levels. International Journal of Molecular Medicine. 38(3). 961–968. 3 indexed citations
3.
Sjögren, Anna-Karin, Björn Glinghammar, Xueqing Li, et al.. (2014). Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes. Archives of Toxicology. 88(7). 1427–1437. 57 indexed citations
4.
Thulin, Petra, Gunnar Nordahl, Marcus Gry, et al.. (2013). Keratin‐18 and micro RNA ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts. Liver International. 34(3). 367–378. 89 indexed citations
5.
Thulin, Petra, Marcus Gry, Gunnar Nordahl, et al.. (2012). Qualification of new biomarkers for drug-induced liver injury in a human cohort. Toxicology Letters. 211. S48–S48.
6.
Rafter, Ingalill, Anna Kotronen, Lisa Strömmer, et al.. (2012). Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans. International Journal of Molecular Medicine. 30(5). 1241–1249. 19 indexed citations
7.
Glinghammar, Björn, Anna‐Lena Berg, Sivert Bjurström, et al.. (2011). Proliferative and Molecular Effects of the Dual PPARα/γ Agonist Tesaglitazar in Rat Adipose Tissues: Relevance for Induction of Fibrosarcoma. Toxicologic Pathology. 39(2). 325–336. 3 indexed citations
8.
Andersson, Jan, Johan Lindberg, Raji Balasubramanian, et al.. (2009). A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran. Biomarkers. 14(8). 572–586. 39 indexed citations
9.
Thulin, Petra, Ingalill Rafter, Céline Tomkiewicz, et al.. (2008). PPARα regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes. Toxicology and Applied Pharmacology. 231(1). 1–9. 51 indexed citations
10.
Kenne, Kerstin, Inger Skånberg, Björn Glinghammar, et al.. (2007). Prediction of drug-induced liver injury in humans by using in vitro methods: The case of ximelagatran. Toxicology in Vitro. 22(3). 730–746. 35 indexed citations
11.
Lindblom, Per Henrik, Ingalill Rafter, C G Copley, et al.. (2007). Isoforms of alanine aminotransferases in human tissues and serum—Differential tissue expression using novel antibodies. Archives of Biochemistry and Biophysics. 466(1). 66–77. 81 indexed citations
12.
Kannisto, Katja, Alexander Chibalin, Björn Glinghammar, et al.. (2006). Differential expression of peroxisomal proliferator activated receptors α and δ in skeletal muscle in response to changes in diet and exercise. International Journal of Molecular Medicine. 17(1). 45–52. 30 indexed citations
13.
Glinghammar, Björn, Josefin Skogsberg, Anders Hamsten, & Ewa Ehrenborg. (2003). PPARδ activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications. 308(2). 361–368. 65 indexed citations
14.
15.
Glinghammar, Björn & Joseph Rafter. (2001). Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells. Gastroenterology. 120(2). 401–410. 59 indexed citations
16.
Haza, Ana I., Björn Glinghammar, Alf Grandien, & Joseph Rafter. (2000). Effect of Colonic Luminal Components on Induction of Apoptosis in Human Colonic Cell Lines. Nutrition and Cancer. 36(1). 79–89. 34 indexed citations
17.
Kok, Theo M. de, Björn Glinghammar, Daniëlle Pachen, et al.. (1999). Bile Acid Concentrations, Cytotoxicity, and pH of Fecal Water from Patients with Colorectal Adenomas. Digestive Diseases and Sciences. 44(11). 2218–2225. 61 indexed citations
18.
Glinghammar, Björn. (1999). Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells. Carcinogenesis. 20(6). 969–976. 43 indexed citations
19.
Rafter, Joseph & Björn Glinghammar. (1998). Interactions between the environment and genes in the colon. European Journal of Cancer Prevention. 7(2). S69–74. 14 indexed citations
20.
Glinghammar, Björn, et al.. (1997). Shift from a dairy product-rich to a dairy product-free diet: influence on cytotoxicity and genotoxicity of fecal water--potential risk factors for colon cancer. American Journal of Clinical Nutrition. 66(5). 1277–1282. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norimasa Miura Breakdown of academic impact, for papers by Alaa E. El‐Sisi Breakdown of academic impact, for papers by Chao Guo Breakdown of academic impact, for papers by Qichao Hu Breakdown of academic impact, for papers by Yanqin Bian Breakdown of academic impact, for papers by Kaili Fu Breakdown of academic impact, for papers by Sandra Kalthoff Breakdown of academic impact, for papers by Nghia Nguyen Breakdown of academic impact, for papers by Jonathan P. Jackson
Rankless by CCL
2026